Resources
About Us
Cardiac Pacemaker Devices Market by Product (Cardiac Pacemaker, Implantable Pacemakers, [Dual Chamber, CRT Pacemaker], External Pacemaker, Pacing Leads), Indication (Arrhythmia, CHF), End User (Hospital & Clinics, Ambulatory Care Centers) - Forecast to 2028
Report ID: MRHC - 10464 Pages: 193 Sep-2021 Formats*: PDF Category: Healthcare Delivery: 2 to 4 Hours Download Free Sample ReportThe increasing prevalence of cardiovascular diseases such as bradycardia & tachycardia; increasing life expectancy; rise in obesity, sedentary lifestyle, & consumption of alcohol; and technological advancements are the key factors driving the growth of the cardiac pacemaker devices market. In addition, the availability of favorable reimbursement scenarios in the developed countries like the U.S. and the U.K. offer significant growth opportunities for the players operating in this market.
The COVID-19 pandemic has adversely hit many economies around the globe. The pandemic has affected more than 100 countries. It led to a significant decrease in elective cardiovascular (CV) procedures, especially in patients with associated chronic diseases such as diabetes mellitus. The emergence of the pandemic urged the Centers for Medicare and Medicaid Services (CMS) in March 2020 to postpone all elective surgeries, non-essential medical procedures, and dental procedures. This included all types of invasive and non-invasive cardiovascular exams and procedures, affecting all facets of cardiology departments, from ECG and echo labs to interventional and EP labs and cardiovascular surgeries. This further impacted the cardiac pacemaker devices market as the total number of pacemaker implantations decreased in 2020 when compared to 2019.
Further, the leading players in the cardiac rhythm management devices market experienced immense losses in their CRM segments. This was due to the cancellation or postponement of cardiovascular procedures resulting in low sales of the cardiac pacemakers devices, thereby negatively impacting the market.
Apart from this, there have been observed cardiac manifestations of coronavirus disease 19. The most common bradyarrhythmia associated with SARS CoV-2 reported worldwide is sinus bradycardia and complete heart block. Cardiac manifestations of COVID-19 have been reported with a higher prevalence described in patients admitted to ICUs. The etiology of cardiac manifestations in COVID-19 patients was multifactorial, including direct viral myocardial damage, hypoxia, hypotension, enhanced inflammatory status, and others. People with frequent or severe sinus bradycardia may need a pacemaker. This is expected to provide opportunities for the cardiac pacemaker devices market in the future.
Click here to: Get Free Sample Pages of this Report
Cardiac pacing has seen a series of game-changing technologies emerge in the past several years spurred by low-power electronics, high-density batteries, improved catheter delivery systems, and innovative software design.
The continuous focus on innovation by the leading players in the cardiac rhythm management devices market, including cardiac pacemakers through increased R&D activities & related investments, have supported the emergence of enhanced pacemakers to offer better healthcare. Some notable advancements in the innovative cardiac pacemaker devices launched during the last three years include miniaturization, complete magnetic resonance imaging (MRI) compatibility, outstanding longevity with enhanced battery life, wireless remote monitoring features, and innovative leadless pacemakers. Many leading players recently launch the MRI-conditional/compatible pacemakers by redesigning the components of pacemakers to minimize heating potential, dislodgement, current induction, and electromagnetic interference.
Further, to overcome the cardiac pacing system problem associated with lead infection, lead failure, and related lead replacement, there has been the introduction of leadless pacemakers. Currently, only single-chamber pacing leadless pacemakers are commercially available, and research to manufacture dual chamber and multi-chamber leadless pacemakers is at the forefront. Also, the pacemakers compatible with technology for remote monitoring with a smartphone or tablet were introduced. These had a higher rate of scheduled transmission success than other remote monitoring options requiring a wand or wireless automatic communication.
Pacemakers can have problems with pacing the intended heart chamber. These kinds of malfunctions could be output failure or capture failure. Other than failure to pace the intended part of the heart, pacemakers can further malfunction when they cannot detect innate signals produced in the heart. Lead displacement is one of the common occurrences with pacemakers that can cause its malfunction.
The majority of reports have stated the following reasons for product recalls: device battery problems and incorrect therapy delivery. In addition, the remaining recalls were attributed to CRTs, leads, implantable artificial organs, and software malfunction.
Thus, the increase in reported cases of cardiac pacemaker malfunction & related product recalls hinders the cardiac pacemaker manufactures market to some extent.
Some of the major factors driving the growth of this segment include the wide adoption of permanent implantable cardiac pacemakers to prevent sudden cardiac deaths (SCD) in patients, increasing incidence of cardiac arrest and atrial fibrillation, increasing trends of modern therapies, and increasing awareness towards healthcare. Also, the advancements fueled by low-power electronics, high-density batteries, enhanced catheter delivery systems in implantable pacemakers result in increased adoption in patients with cardiovascular diseases, thereby driving the segment growth.
Some of the major factors driving the growth of this segment include the changes in the lifestyle among the population, adoption of a disease-causing sedentary lifestyle, excessive alcohol consumption, and smoking.
Some of the major factors driving the growth of this segment include the rising preference for ambulatory surgery centers for pacemaker brands implantation & related procedures by the patients to avoid waiting time at hospitals and the need to reduce the cost associated with hospitalization.
At the regional level, North America is expected to account for the largest share of the cardiac pacemaker devices market in 2021. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period. The increasing burden of patients with hypertension and CVDs, changing lifestyle, rising public & private spending for the development of proper healthcare infrastructure, and rising focus of the key players to expand in emerging countries like China & India are the factors propelling the regional growth.
Key Players
The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over the past four years. The key players profiled in the global cardiac pacemaker devices market are Medtronic Public Limited Company (Ireland), Boston Scientific Corporation (U.S.), Biotronik SE & Co. KG (Germany), Abbott Laboratories (U.S.), MEDICO S.p.A. (Italy), Shree Pacetronix Ltd. (India), Lepu Medical Group (China), Osypka Medical GmbH (Germany), OSCOR Inc. (U.S.), and MicroPort Scientific Corporation (China), among others.
Cardiac Pacemaker Devices Market, by Product
Cardiac Pacemaker Devices Market, by Indication
Cardiac Pacemaker Devices Market, by End User
Cardiac Pacemaker Devices Market, by Geography
Key questions answered in the report:
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for this Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Geriatric Population
4.2.2. Increasing Burden of Cardiovascular Diseases
4.2.3. Rise in Obesity, Sedentary Lifestyle, & Excessive Consumption of Alcohol
4.2.4. Technological Advancements
4.3. Restraints
4.3.1. Increase in Reported Cases of Cardiac Pacemaker Malfunction & Product Recalls
4.4. Opportunities
4.4.1. Favourable Reimbursement Scenario in the U.S.
4.5. Challenges
4.5.1. Shortage of Medical Professionals
4.6. Trends
4.6.1. Use of MRI-Safe and MRI Conditional Pacemakers
4.7. Impact of Covid 19 Pandemic on Cardiac Pacemaker Devices Market
5. Regulatory Analysis – Cardiac Pacemaker Devices Market
5.1. Introduction
5.2. North America
5.3. Europe
5.4. Asia-Pacific
5.5. Latin America and the Middle East & Africa
6. Pricing Analysis – Cardiac Pacemaker Devices Market
6.1. Introduction
7. Global Cardiac Pacemaker Devices Market, by Type
7.1. Introduction
7.2. Cardiac Pacemakers
7.2.1. Implantable Pacemakers
7.2.1.1. Dual-chamber Pacemakers
7.2.1.2. Single-chamber Pacemakers
7.2.1.3. Biventricular Pacemakers
7.2.2. External Pacemakers
7.3. Pacing Leads
7.4. Pacing Analyzers
8. Global Cardiac Pacemaker Devices Market, by Indication
8.1. Introduction
8.2. Arrhythmia
8.3. Congestive Heart Failure
8.4. Other Indications
9. Global Cardiac Pacemaker Devices Market, by End User
9.1. Introduction
9.2. Hospitals & Clinics
9.3. Ambulatory Surgery Centers
9.4. Other End Users
10. Cardiac Pacemaker Devices Market, by Geography
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. U.K.
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe (RoE)
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia-Pacific (RoAPAC)
10.5. Latin America
10.6. Middle East & Africa
11. Competitive Landscape
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2020)
11.4.1. Medtronic Public Limited Company (Ireland)
11.4.2. Abbott Laboratories (U.S.)
11.4.3. Boston Scientific Corporation (U.S.)
12. Company Profiles
12.1. Medtronic Public Limited Company
12.1.1. Business Overview
12.1.2. Financial Overview
12.1.3. Product Portfolio
12.1.4. Strategic Developments
12.2. Boston Scientific Corporation
12.2.1. Business Overview
12.2.2. Financial Overview
12.2.3. Product Portfolio
12.3. Biotronik SE & Co. KG
12.3.1. Business Overview
12.3.2. Product Portfolio
12.4. Abbott Laboratories
12.4.1. Business Overview
12.4.2. Financial Overview
12.4.3. Product Portfolio
12.5. MEDICO S.p.A.
12.5.1. Business Overview
12.6. Shree Pacetronix Ltd.
12.6.1. Business Overview
12.6.2. Financial Overview
12.6.4. Product Portfolio
12.7. Lepu Medical Group
12.7.1. Business Overview
12.7.2. Product Portfolio
12.8. Osypka Medical GmbH
12.8.1. Business Overview
12.8.2. Product Portfolio
12.9. OSCOR Inc.
12.9.1. Business Overview
12.9.2. Product Portfolio
12.10. MicroPort Scientific Corporation
12.10.1. Business Overview
12.10.2. Financial Overview
12.10.4. Product Portfolio
13. Appendix
13.1. Questionnaire
13.2. Available Customization
List of Tables
Table 1 Global Cardiac Pacemaker Devices Market Drivers: Impact Analysis (2021-2028)
Table 2 Prevalence of Smoking (2018)
Table 3 Tobacco Use Among Students (2020)
Table 4 List of Innovative Cardiac Pacemakers Launched With Enhanced Features
Table 5 Global Cardiac Pacemaker Devices Market Restraints: Impact Analysis (2021-2028)
Table 6 Number of Cardiac Implant Recalls & Total Recall Reports 2004-2014
Table 7 Nationally Covered Indications for Single and Dual Chamber Cardiac Pacemakers
Table 8 Coding and Reimbursement for Pacemakers
Table 9 Projected Physician Shortages by 2033
Table 10 Main Modifications introduced in MRI-Conditional Pacing Systems
Table 11 MR Conditional Pacemakers and Leads Approved by the U.S. Food And Drug Administration
Table 12 Revenue Loses Due to the Covid-19 Pandemic (2019 VS 2020)
Table 13 Summary of Cardiac Pacemaker Devices in Canada
Table 14 Regulatory Bodies for Cardiac Pacemaker Devices in European Countries
Table 15 Cardiac Pacemaker Devices Regulations in Asia-Pacific Region
Table 16 Cardiac Pacemaker Device Regulation in the Rest of the World
Table 17 Cost Comparison: Cardiac Pacemakers and Pacing Leads
Table 18 Global Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 19 Global Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 20 Global Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 21 Global Cardiac Pacemakers Market Size, by Country/Region, 2019–2028 (Million)
Table 22 Global Cardiac Pacemakers Market Size, by Country/Region, 2019–2028 (Units)
Table 23 Key Companies Offering Implantable Cardiac Pacemakers
Table 24 Global Implantable Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 25 Global Implantable Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 26 Global Implantable Pacemakers Market Size, by Country/Region, 2019–2028 (USD Million)
Table 27 Global Implantable Pacemakers Market Size, by Country/Region, 2019–2028 (Units)
Table 28 Key Companies offering Dual-Chamber Cardiac Pacemakers
Table 29 Global Dual-Chamber Pacemakers Market Size, by Country/Region, 2019–2028 (USD Million)
Table 30 Global Dual-Chamber Pacemakers Market Size, by Country/Region, 2019–2028 (Units)
Table 31 Key Companies Offering Single-Chamber Cardiac Pacemakers
Table 32 Global Single-Chamber Pacemakers Market Size, by Country/Region, 2019–2028 (USD Million)
Table 33 Global Single-Chamber Pacemakers Market Size, by Country/Region, 2019–2028 (Units)
Table 34 Key Companies Offering Biventricular Cardiac Pacemakers
Table 35 Global Biventricular Pacemakers Market Size, by Country/Region, 2019–2028 (USD Million)
Table 36 Global Biventricular Pacemakers Market Size, by Country/Region, 2019–2028 (Units)
Table 37 Key Companies Offering External Cardiac Pacemakers
Table 38 Global External Pacemakers Market Size, by Country/Region, 2019–2028 (USD Million)
Table 39 Global External Pacemakers Market Size, by Country/Region, 2019–2028 (Units)
Table 40 Key Companies Offering Pacing Leads
Table 41 Global Pacing Leads Market Size, by Country/Region, 2019–2028 (USD Million)
Table 42 Key Companies Offering Pacing Analyzers
Table 43 Global Pacing Analyzers Market Size, by Country/Region, 2019–2028 (USD Million)
Table 44 Global Cardiac Pacemaker Devices Market Size, by Indication, 2019 – 2028 (USD Million)
Table 45 Global Cardiac Pacemaker Devices Market Size for Arrhythmia, by Country/Region, 2019 – 2028 (USD Million)
Table 46 Global Cardiac Pacemaker Devices Market Size for Congestive Heart Failure, by Country/Region, 2019 – 2028 (USD Million)
Table 47 Global Cardiac Pacemaker Devices Market Size for Other indications, by Country/Region, 2019 – 2028 (USD Million)
Table 48 Global Cardiac Pacemaker Devices Market Size, by End User, 2019 – 2028 (USD Million)
Table 49 Reimbursement Prospect for Hospital Outpatient Procedures in the U.S., 2016 – 2020 (USD)
Table 50 The Number of Hospitals, by Country, 2019
Table 51 Global Cardiac Pacemaker Devices Market Size for Hospitals & Clinics, by Country/ Region, 2019–2028 (USD Million)
Table 52 Changes in Ambulatory Surgery Center Reimbursement Fee Schedule in the U.S., 2016–2020 (USD)
Table 53 Reimbursement Prospect of Ambulatory Surgical Center in the U.S., by Procedure, 2016 – 2020 (USD)
Table 54 Global Cardiac Pacemaker Devices Market Size for Ambulatory Surgery Centers, by Country/ Region, 2019–2028 (USD Million)
Table 55 Cardiac Pacemaker Devices Market Size for Other End Users, by Country/ Region, 2019–2028 (USD Million)
Table 56 Global Cardiac Pacemaker Devices Market Size, by Country/Region, 2019 – 2028 (USD Million)
Table 57 North America: Cardiac Pacemaker Devices Market Size, by Country, 2019–2028 (USD Million)
Table 58 North America: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 59 North America: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 60 North America: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 61 North America: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 62 North America: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 63 North America: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 64 North America: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 65 U.S.: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 66 U.S.: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 67 U.S.: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 68 U.S.: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 69 U.S.: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 70 U.S.: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 71 U.S.: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 72 Inpatient Hospitalization and Day Surgery Costs for Implantable Medical Device (IMD) Procedures, Canada
Table 73 Canada: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 74 Canada: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 75 Canada: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 76 Canada: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 77 Canada: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 78 Canada: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 79 Canada: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 80 Europe: Cardiac Pacemaker Devices Market Size, by Country/Region, 2019–2028 (USD Million)
Table 81 Europe: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 82 Europe: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 83 Europe: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 84 Europe: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 85 Europe: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 86 Europe: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 87 Europe: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 88 The Role of CVDs in The top Causes of Death in Germany With Related Statistics (2019)
Table 89 Germany: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 90 Germany: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 91 Germany: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 92 Germany: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 93 Germany: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 94 Germany: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 95 Germany: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 96 Total Deaths by Cause in the U.K. (2019)
Table 97 U.K.: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 98 U.K.: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 99 U.K.: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 100 U.K.: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 101 U.K.: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 102 U.K.: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 103 U.K.: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 104 France: Cardiac Pacemaker manufacture Market Size, by Type, 2019–2028 (USD Million)
Table 105 France: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 106 France: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 107 France: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 108 France: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 109 France: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 110 France: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 111 Italy: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 112 Italy: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 113 Italy: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 114 Italy: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 115 Italy: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 116 Italy: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 117 Italy: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 118 Spain: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 119 Spain: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 120 Spain: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 121 Spain: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 122 Spain: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 123 Spain: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 124 Spain: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 125 RoE: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 126 RoE: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 127 RoE: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 128 RoE: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 129 RoE: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 130 RoE: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 131 RoE: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 132 Asia-Pacific: Cardiac Pacemaker Devices Market Size, by Country/Region, 2019–2028 (USD Million)
Table 133 Asia-Pacific: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 134 Asia-Pacific: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 135 Asia-Pacific: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 136 Asia-Pacific: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 137 Asia-Pacific: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 138 Asia-Pacific: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 139 Asia-Pacific: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 140 China: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 141 China: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 142 China: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 143 China: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 144 China: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 145 China: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 146 China: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 147 Japan: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 148 Japan: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 149 Japan: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 150 Japan: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 151 Japan: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 152 Japan: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 153 Japan: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 154 Payment Statistics for Pacemakers and CRT in India (2014–2017)
Table 155 India: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 156 India: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 157 India: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 158 India: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 159 India: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 160 India: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 161 India: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 162 RoAPAC: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 163 RoAPAC: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 164 RoAPAC: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 165 RoAPAC: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 166 RoAPAC: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 167 RoAPAC: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 168 RoAPAC: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 169 Number of Pacemaker Implants at Hospital Nacional Edgardo Rebagliati Martins in Peru 2019 Vs 2020
Table 170 Latin America: Cardiac Pacemaker Devices Market Size, by Type, 2019–2028 (USD Million)
Table 171 Latin America: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 172 Latin America: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 173 Latin America: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 174 Latin America: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 175 Latin America: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 176 Latin America: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 177 Middle East & Africa: Cardiac Pace maker brands Market Size, by Type, 2019–2028 (USD Million)
Table 178 Middle East & Africa: Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 179 Middle East & Africa: Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 180 Middle East & Africa: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (USD Million)
Table 181 Middle East & Africa: Implantable Cardiac Pacemakers Market Size, by Type, 2019–2028 (Units)
Table 182 Middle East & Africa: Cardiac Pacemaker Devices Market Size, by Indication, 2019–2028 (USD Million)
Table 183 Middle East & Africa: Cardiac Pacemaker Devices Market Size, by End User, 2019–2028 (USD Million)
Table 184 Recent Developments, by Company, 2018–2021
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side& Demand-Side)
Figure 6 Market Size Estimation
Figure 7 Global Cardiac Pacemaker Devices Market Size, by Type, 2021 VS. 2028 (USD Million)
Figure 8 Global Cardiac Pacemaker Devices Market Size, by Indication, 2021 VS. 2028 (USD Million)
Figure 9 Hospitals & Clinics Expected to Dominate the Global Cardiac Pacemaker Devices Market
Figure 10 Cardiac Pacemaker Devices Market, by Region
Figure 11 Market Dynamics
Figure 12 Population Aged 65 Years or Over, by Region: 2019 and 2050
Figure 13 Global Cardiovascular Diseases Deaths by Type, 2018 VS 2030
Figure 14 Alcohol Consumption Among Persons (Age 15+) in Liters Per Capita Per Year
Figure 15 Projected Physician Demand And Physician Supply for the U.S. (2019–2030)
Figure 16 Total No of Pacemaker Implants at Hospital Nacional Edgardo Rebagliati Martins (2019-2020)
Figure 17 Price Trend for Cardiac Pacemakers (2016–2020)
Figure 18 Global Cardiac Pacemaker Devices Market Size, by Type, 2021-2028 (USD Million)
Figure 19 Global Cardiac Pacemaker Devices Market Size, by Indication, 2021–2028 (USD Million)
Figure 20 Global Cardiac Pacemaker Devices Market Size, by End User, 2021-2028 (USD Million)
Figure 21 Number of Medicare-certified Ambulatory Surgical Centers in the U.S., 2010-2019
Figure 22 Global Cardiac Pacemaker Devices Market, by Region, 2021–2028 (USD Million)
Figure 23 Geographic Snapshot: North American Cardiac Pacemaker Devices Market
Figure 24 Geriatric Population as a Percentage of Total Population in the U.S., 2018-2019-2020, 2030, 2040, 2050
Figure 25 Cardiovascular Diseases Prevalence Rate in the U.S. Population, 2015-2035
Figure 26 Overweight and Obesity Rate in Adult Women Population in Canada, 2010-2030
Figure 27 Snapshot of Cardiovascular Disease in Europe, 2019
Figure 28 Geographic Snapshot: European Cardiac Pacemaker Devices Market
Figure 29 France: Percentage of Older People (65 Years and Above), 2012–2050
Figure 30 Pacemaker Implantation in Spain, 2010-2018 (Pacemaker Implantations/Million Population)
Figure 31 Geographic Snapshot: Asia-Pacific Cardiac Pacemaker Devices Market
Figure 32 Number of Person Aged 60 Years & Above in Latin America, 2015–2030
Figure 33 Pacemaker Implantation Rates Per Million Populations: 2014-2018
Figure 34 Key Growth Strategies Adopted by Leading Players, 2018–2021
Figure 35 Cardiac Pacemaker Devices Market: Competitive Benchmarking, by Product
Figure 36 Market Share Analysis: Cardiac Pacemaker Devices Market, 2020
Figure 39 Abbott Laboratories: Financial Overview, 2020
Figure 40 Shree Pacetronix Ltd.: Financial Overview, 2020
Figure 41 MicroPort Scientific Corporation.: Financial Overview, 2020
Published Date: Nov-2024
Published Date: Aug-2024
Published Date: Aug-2024
Published Date: Jun-2024
Published Date: Jun-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates